Ebronucimab Biosimilar - Research Grade

Human

PCSK9ï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q8NBP7

Blue ice

PCSK9 governs LDL receptor degradation and circulating cholesterol levels, making it a heavily studied target in cardiovascular and lipid metabolism research. Our research-grade anti-human PCSK9 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of ebronucimab, provided for research use only (RUO). Produced under stringent in vivo standards, this ultra-pure, low-endotoxin material is available in scalable milligram (mg) to gram (g) quantities to meet heavy-usage, high-throughput laboratory needs. It serves as a consistent control and neutralizing reagent for binding assays, in vitro receptor-recycling screens, and in vivo models of cholesterol regulation.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks